COVID-19 ACIP Vaccine Recommendations
Advisory Committee on Immunization Practices (ACIP)
Published in Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT COVID-19 Vaccine Recommendations
- MMWR; December 22, 2020;69
The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020
Print version pdf icon[5 pages]- See also:
- Evidence Table for COVID-19 Vaccines Allocation in Phases 1b and 1c of the Vaccination Program
- Interim Considerations for Phased Implementation of COVID-19 Vaccination and Sub-Prioritization Among Recommended Populations
- Vaccination Implementation Strategies to Consider for Populations Recommended to Receive Initial Doses of COVID-19 Vaccine (Persons included in Phases 1a-1c)
- See also:
- MMWR; December 20, 2020;69
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
Print version pdf icon[4 pages]
- MMWR; December 13, 2020;69
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
Print version pdf icon[3 pages] - MMWR; December 3, 2020;69
The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020
Print version pdf icon[3 pages]- See also:
Page last reviewed: December 22, 2020
Content source: National Center for Immunization and Respiratory Diseases